The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents
选择性 GSK3 抑制剂 SAR502250 表现出神经保护活性,并减轻啮齿动物阿尔茨海默病神经精神症状模型中的行为障碍
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-019-54557-5
Guy Griebel, Jeanne Stemmelin, Mati Lopez-Grancha, Denis Boulay, Gerald Boquet, Franck Slowinski, Philippe Pichat, Sandra Beeské, Shinji Tanaka, Akiko Mori, Masatake Fujimura, Junichi Eguchi